Presented to you this morning the Major Catalyst t

TYSONS CORNER, Va., Feb. 19, 2014 (GLOBE NEWSWIRE) -- ScripsAmerica Inc. (OTCBB:SCRC), today announced that the Company has commenced the prepayment of its outstanding convertible debt by issuing the first payment on its convertible note with the largest principal and closest conversion date.

ScripsAmerica has announced the prepayment of several convertible notes prior to their conversion date in 2013 and the Company's management continues to hold such actions as a top priority in order to maximize shareholder value by preventing the potential dilution of its common stock.

ScripsAmerica's CEO, Bob Schneiderman, commented, "Last year, ScripsAmerica entered into several convertible note agreements with funding sources as was necessary to fund the company's operations and enable Scrips to add additional revenue streams. I can assure our shareholders that the company has not taken on any additional convertible debt since October 22 ^nd of last year. Moving forward we will not add any more of this type of debt to our balance sheet as we are experiencing growth in our existing areas of business and expect increased revenue based on new ventures and products. ScripsAmerica will continue to prepay our existing notes prior to their conversion date as funds permit."

About ScripsAmerica, Inc.

ScripsAmerica, Inc. is a supplier of prescription, OTC and nutraceutical drugs, delivering pharmaceutical products to a wide range of end users across the health care industry. End users include retail pharmacies, hospitals, long-term care facilities and government and home care agencies. For more information, visit www.ScripsAmerica.com .